Detalles MARC
| 000 -LEADER |
|---|
| fixed length control field |
03544nam a2200205 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
00008644 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20230312181425.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
071224s20032003cl d g 001 0 engsd |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DO-SdBDB |
| Language of cataloging |
spa |
| Transcribing agency |
DO-SdBDB |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 043 ## - GEOGRAPHIC AREA CODE |
|---|
| Geographic area code |
cl |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
HD 47 .4 |
| Item number |
.M35 2003 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Making choices in health : |
| Remainder of title |
who guide to cost-effectiveness analysis / |
| Statement of responsibility, etc. |
edited by Tessa Tan-Torres Edejer, Rob Baltussen, Taghreed Adam, Raymond Hutubessy, Arnab. Acharya, David B. Evans and Christopher J.L. Murray. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Geneva : |
| Name of publisher, distributor, etc. |
World Health Organization, |
| Date of publication, distribution, etc. |
2003. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxii, 318 páginas : |
| Other physical details |
ilustradas con gráficos ; |
| Dimensions |
23 cm. |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Preface, ix -- |
| Title |
List of acronyms and abbreviations, xxi -- |
| -- |
Part one. Methods for generalized cost-effectiveness analysis -- |
| -- |
1. What is generalized cost-effectiveness analysis?, 3 -- |
| -- |
2. Undertaking a study using GCEA, 17 -- |
| -- |
3. Estimating costs, 29 -- |
| -- |
4. Estimating health effects, 49 -- |
| -- |
5. Discounting, 67 -- |
| -- |
6. Uncertainty in cost-effectiveness analysis, 73 -- |
| -- |
7. Policy uses of Generalized CEA, 83 -- |
| -- |
8. Reporting CEA results, 91 -- |
| -- |
9. Summary of recommendations, 93 -- |
| -- |
References, 97 -- |
| -- |
Annex A. Who-choice activities on generalized cost-effectiveness analysis, 107 -- |
| -- |
Annex B. Draft list of intervention clusters for evaluation / |
| Statement of responsibility |
by Who-Choice, 110 -- |
| Title |
Annex C. An illustration of the types of costs included in a selection of intervention activities at central levels, 111 -- |
| -- |
Annex D. Interpreting international dollars, 112 -- |
| -- |
Annex E. Dalys to measure burden of disease, 113 -- |
| -- |
Annex F. Measuring intervention benefit at the population level, 115 -- |
| -- |
Annex G. Epidemiological subregions as applied in WHO generalized CEA, 118 -- |
| -- |
Endnotes, 119 -- |
| -- |
Part two. Background papers and applications -- |
| -- |
1. Development of who guidelines on generalized cost-effectiveness analysis / |
| Statement of responsibility |
Christopher J.L. Murray, David B. Evans, Arnab Acharya, Rob M.P.M. Baltussen, 125 -- |
| Title |
2. PopMod: A longitudinal population model with two interacting disease states / |
| Statement of responsibility |
Jeremy A. Lauer, Klaus Rohrich, Harold Wirth, Claude Charette, Steve Gribble, Christopher J.L. Murray, 151 -- |
| Title |
3. Programme costs in the economic evaluation of health interventions / |
| Statement of responsibility |
Benjamin Johns, Rob Baltussen, Raymond Hutubessy, 177 -- |
| Title |
4. Econometric estimation of country-specific hospital costs / |
| Statement of responsibility |
Taghreed Adam, David B. Evans, Christopher J.L. Murray, 197 -- |
| Title |
5. Stochastic league tables: communicating cost-effectiveness results to decision-makers / |
| Statement of responsibility |
Raymond C. W. Hutubessy, Rob M.P.M. Baltussen, David B. Evans, Jan J. Barendregt, Christopher J.L. Murray, 217 -- |
| Title |
6. Uncertainty in cost-effectiveness analysis: probabilistic uncertainty analysis and stochastic league tables / |
| Statement of responsibility |
Rob M.P.M. Baltussen, Raymond C. W. Hutubessy, David B. Evans, Christopher J.L. Murray, 225 7. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk / |
| -- |
Christopher J.L. Murray, Jeremy A. Lauer, Raymond C. W. Hutubessy, Louis Niessen, Niels Tomijima, Anthony Rodgers, Carlene M.M. Lawes, David B. Evans, 237 -- |
| Title |
8. Generalized cost-effectiveness analysis: an aid to decision making in health / |
| Statement of responsibility |
Raymond C. W. Hutubessy, Rob M.P.M. Baltussen, Tessa Tan-Torres Edejer, David B. Evans, 277 -- |
| Title |
9. Ethical issues in the use of cost effectiveness analysis for the prioritization of health care resources / |
| Statement of responsibility |
Dan W. Brock, 289 -- |
| Title |
Index, 313. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Análisis costo-beneficio. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Salud. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Monografía - Colección General |
